Funding for this research was provided by:
National Human Genome Research Institute (HG002585, RM1HG008935)
National Institute of Mental Health (R01MH110531)
Received: 13 March 2019
Accepted: 11 May 2020
First Online: 29 June 2020
: C.H. is a founder and scientific advisory board member of Accent Therapeutics and a shareholder of Epican Genentech.